Jeffrey W. Sherman, EVP and Chief Medical Officer at Horizon Therapeutics Public Ltd Co (HZNP), sold 65,235 shares at $111.44 ($6.3M) on 2022-12-12, disclosed to the SEC on 2022-12-13.
Open-market sale of $6.3M HZNP by EVP and Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 8,531 | $0 | 0.0% |
| 2 | $111.44 | 6,974 | $777K | 12.3% |
| 3 | $111.44 | 6,974 | $777K | 12.3% |
| 4 | $111.45 | 21,378 | $2.4M | 37.7% |
| 5 | $111.45 | 21,378 | $2.4M | 37.7% |
| Total | $96.87 avg | 65,235 |
| $6.3M |
| 100% |
| Filing → |
| XERS | BUY | 2023-11-29 | $10K | — | Filing → |
| HZNP | SELL | 2023-01-12 | $1.5M | — | Filing → |
| HZNP | SELL | 2023-01-06 | $1.2M | — | Filing → |